Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes
Author(s) -
Andreas Heinzel,
Michael Kammer,
Gert Mayer,
Roman ReindlSchwaighofer,
Karin Hu,
Paul Perco,
Susanne Eder,
László Rosivall,
Patrick B. Mark,
Wenjun Ju,
Matthias Kretzler,
Peter S. Gilmour,
Jonathan M. Wilson,
Kevin L. Duffin,
Moustafa Abdalla,
Mark I. McCarthy,
Georg Heinze,
Hiddo J.L. Heerspink,
Andrzej Więcek,
Maria F. Gomez,
Rainer Oberbauer
Publication year - 2018
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc18-0532
Subject(s) - medicine , biomarker , type 2 diabetes , prospective cohort study , renal function , diabetes mellitus , cohort , creatinine , oncology , cohort study , endocrinology , biochemistry , chemistry
The decline of estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes is variable, and early interventions would likely be cost-effective. We elucidated the contribution of 17 plasma biomarkers to the prediction of eGFR loss on top of clinical risk factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom